Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2024)
Dr Reddys Laboratories (RDY) posted Non Operating Income of -$5.2 million for Q4 2024, up 55.74% on a QoQ basis from -$11.7 million in Q3 2024, and up 55.23% year-over-year from -$3.3 million in Q1 2024.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Non Operating Income (2009 - 2024) Analysis & Trends
Dr Reddys Laboratories has reported Non Operating Income for 3 years, with the latest figure at -$5.2 million in Q4 2024.
- On a quarterly basis, Non Operating Income rose 55.23% year-over-year to -$5.2 million in Q4 2024; TTM through Dec 2024 was -$36.5 million, a 61.23% decrease from a year earlier, with the FY2024 full-year figure at -$50.7 million, changed N/A from the prior year.
- Non Operating Income was -$5.2 million for Q4 2024 at Dr Reddys Laboratories, up from -$11.7 million in the prior quarter.
- The five-year high for Non Operating Income was -$5.2 million in Q4 2024, with the low at -$11.7 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -224.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -58.78 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -1.19 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 278,000.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -5.20 Mn |
| Sep 30, 2024 | -11.75 Mn |
| Mar 31, 2024 | -7.90 Mn |
| Dec 31, 2023 | -11.61 Mn |
| Jun 30, 2009 | -3.00 Mn |